In the Clinical Correlate of Brain SPECT Perfusion Abnormalities in Fibromyalgia study published in November 2008 in the Journal of Nuclear Medicine, French researchers discovered a brain abnormality in fibromyalgia patients. (more…)
In late June, the FDA approved Cymbalta for treating fibromyalgia related pain. Cymbalta belongs to a class of drugs called serotonin-norepinephrine reuptake inhibitors and has proven to reduce chronic pain in patients. Cymbalta is also approved for use in treating depression and anxiety. (more…)
A report published by Frank Leavitt, PhD and Robert S. Katz, MD, in the Journal of Clinical Rheumatology, highlights a previously overlooked symptom that affects many fibromyalgia patients. (more…)
